A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
about
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study Evaluating Trastuzumab ...... (HER2)-Positive Breast Cancer
@en
type
label
A Study Evaluating Trastuzumab ...... (HER2)-Positive Breast Cancer
@en
prefLabel
A Study Evaluating Trastuzumab ...... (HER2)-Positive Breast Cancer
@en
P17
P4844
P6153
P1476
A Randomized, Multicenter, Ope ...... th HER2-Positive Breast Cancer
@en
P3098
NCT02131064
P580
2014-06-30T00:00:00Z
P582
2015-12-31T00:00:00Z